AI in drug development: A reality check
In this episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery really is.
Separating the hype from the reality has always been a challenge when it comes to AI, and Prakash believes that many in the industry are giving the technology too much credit as a drug development game changer.
Jonah and Adityo break down how current AI systems work and discuss the inherent limitations of AI. And Adityo suggests some of the best ways to use the technology as a tool to support drug development.
As the show goes on, they also dive into other applications of AI across the industry, where it works, and where it needs to be combined with human expertise. Tune in for an AI reality check and a more sceptical perspective on a hype-laden topic.
You can listen to episode 87 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series in iTunes, Spotify, acast, Stitcher, and Podbean.
